[Beta-blockers in cardiac insufficiency: should they always be considered in the therapeutic strategy? Arguments against].


The evidence supporting the use of beta-adrenergic blockers in the treatment of heart failure secondary to systolic dysfunction is reviewed. Up to date, seven controlled trials of carvedilol in patients with heart failure have been published. It has been concluded that the use of the non-selective, third generation beta-adrenergic blockers, with alpha… (More)


  • Presentations referencing similar topics